109494 ⎘
Coculture with; Conditioned medium produced by genetically modified cells
METHODS FOR EXPANDING SARS-COV2-ANTIGEN-SPECIFIC T CELLS, COMPOSITIONS AND USES RELATED THERETO
#2MONOCLONAL ANTIBODY ISOLATION
#3CRISPR/CAS SCREENING PLATFORM TO IDENTIFY GENETIC MODIFIERS OF TAU SEEDING OR AGGREGATION
#4CELL CULTURE PLATFORM FOR SINGLE CELL SORTING AND ENHANCED REPROGRAMMING OF IPSCS
#5GENOME EDITED CANCER CELL VACCINES
#6THYMIC EPITHELIAL CELL PRODUCTION METHOD
#7INDUCED LIVER SINUSOIDAL ENDOTHELIAL CELLS (iLSECs) AND METHODS FOR SUPPORTING HEPATOCYTES USING THE iLSECs
#8T CELL PRODUCTION METHOD
#9CRISPR/CAS SCREENING PLATFORM TO IDENTIFY GENETIC MODIFIERS OF TAU SEEDING OR AGGREGATION
#10VIRAL VECTOR PRODUCTION SYSTEM
#11PROCESSING OF TUMOR INFILTRATING LYMPHOCYTES
#12METHODS FOR EXPANDING T CELLS FOR THE TREATMENT OF CANCER AND RELATED MALIGNANCIES
#13METHODS FOR REDUCING ELEVATED GLUCOSE LEVELS
#14METHODS FOR REPROGRAMMING CELLS AND USES THEREOF
#15METHODS FOR ENGINEERING ALLOGENEIC AND IMMUNOSUPPRESSIVE RESISTANT T CELL FOR IMMUNOTHERAPY
#16CHIMERIC HLA ACCESSORY RECEPTOR
#17Somatic Cell Reprogramming
#18CD19 SPECIFIC CHIMERIC ANTIGEN RECEPTOR AND USES THEREOF
#19ENGINEERED HLA MOLECULES USEFUL FOR T CELL AND NK CELL ACTIVATION AND EXPANSION
#20STING DEPENDENT ADJUVANTS
#21ASSAY
#22GENETICALLY MODIFIED STEM CELLS
#23DIFFERENTIAL ADHESION AND TENSION GUIDED FORMATION OF STEM CELL DERIVED EMBRYOS
#24METHODS FOR EXPANDING IMMUNE CELLS
#25CRISPR/Cas screening platform to identify genetic modifiers of tau seeding or aggregation
#26ARTIFICIAL ANTIGEN-PRESENTING CELL
#27DELIVERY OF MOLECULES TO CELLS USING TROGOCYTOSIS AND ENGINEERED CELLS
#28PERSONALIZED FUSION CELL VACCINES
#29CD40L EXPRESSING MAMMALIAN CELLS AND THEIR USE
#30TISSUE ORGANOIDS
#31METHOD FOR THE GENERATION OF GENETICALLY MODIFIED CELLS
#32WNT PATHWAY STIMULATION IN REPROGRAMMING SOMATIC CELLS WITH NUCLEAR REPROGRAMMING FACTORS
#33GENETICALLY MANIPULATED CELL STRAIN FOR ACTIVATING AND AMPLIFYING NK CELLS AND USE THEREOF
#34METHODS OF ISOLATING T CELL RECEPTORS HAVING ANTIGENIC SPECIFICITY FOR A CANCER-SPECIFIC MUTATION
#35METHODS FOR ENGINEERING ALLOGENEIC AND HIGHLY ACTIVE T CELL FOR IMMUNOTHERAPHY
#36OVERCOMING IMMUNE SUPPRESSION WITH TGF-B RESISTANT NK CELLS
#37METHODS FOR RAPID CLONING AND EXPRESSION OF HLA CLASS I CELLS
#38METHODS FOR ENGINEERING HIGHLY ACTIVE T CELL FOR IMMUNOTHERAPHY
#39METHODS FOR ENGINEERING ALLOGENEIC AND HIGHLY ACTIVE T CELL FOR IMMUNOTHERAPHY
#40Restimulation of cryopreserved tumor infiltrating lymphocytes
#41METHODS AND COMPOSITIONS FOR ENHANCED EXPANSION AND CYTOTOXICITY OF NATURAL KILLER CELLS
#42Restimulation of cryopreserved tumor infiltrating lymphocytes
#43Restimulation of cryopreserved tumor infiltrating lymphocytes
#44Restimulation of cryopreserved tumor infiltrating lymphocytes
#45RESTIMULATION OF CRYOPRESERVED TUMOR INFILTRATING LYMPHOCYTES
#46Restimulation of cryopreserved tumor infiltrating lymphocytes
#47BACTERIA-ENGINEERED TO ELICIT ANTIGEN-SPECIFIC T-CELLS
#48USE OF PRE T ALPHA OR FUNCTIONAL VARIANT THEREOF FOR EXPANDING TCR ALPHA DEFICIENT T CELLS
#49METHODS OF B CELL EXPANSION FOR USE IN CELL THERAPY
#50Engineered Artificial Antigen Presenting Cells for Tumor Infiltrating Lymphocyte Expansion
#51Engineered Artificial Antigen Presenting Cells for Tumor Infiltrating Lymphocyte Expansion
#52METHODS FOR EXPANDING T CELLS FOR THE TREATMENT OF CANCER AND RELATED MALIGNANCIES
#53GENETICALLY MODIFIED NK CELLS AND USES THEREOF
#54METHODS OF PRODUCING MODIFIED NATURAL KILLER CELLS AND METHODS OF USE
#55USE OF PRE T ALPHA OR FUNCTIONAL VARIANT THEREOF FOR EXPANDING TCR ALPHA DEFICIENT T CELLS
#56Genetically modified stem cells
#57Restimulation of cryopreserved tumor infiltrating lymphocytes
#58Universal Killer T-Cell
#59Restimulation of cryopreserved tumor infiltrating lymphocytes
#60Restimulation of cryopreserved tumor infiltrating lymphocytes
#61Restimulation of cryopreserved tumor infiltrating lymphocytes
#62Antibody binding to human IL-1β, preparation method therefor and use thereof
#63Restimulation of cryopreserved tumor infiltrating lymphocytes
#64Restimulation of cryopreserved tumor infiltrating lymphocytes
#65Restimulation of cryopreserved tumor infiltrating lymphocytes
#66Restimulation of cryopreserved tumor infiltrating lymphocytes
#67Restimulation of cryopreserved tumor infiltrating lymphocytes
#68Restimulation of cryopreserved tumor infiltrating lymphocytes
#69Methods for expanding SARS-COV2-antigen-specific t cells, compositions and uses related thereto
#70Genetically modified stem cells
#71USE OF PDL1 EXPRESSING CELLS TO CONVERT T CELLS INTO REGULATORY T CELLS
#72Restimulation of cryopreserved tumor infiltrating lymphocytes
#73Restimulation of cryopreserved tumor infiltrating lymphocytes
#74Restimulation of cryopreserved tumor infiltrating lymphocytes
#75CHIMERIC HLA ACCESSORY RECEPTOR
#76Use of pre T alpha or functional variant thereof for expanding TCR alpha deficient T cells
#77POLYCLONAL GAMMA DELTA T CELLS FOR IMMUNOTHERAPY
#78VIRAL VECTOR PRODUCTION SYSTEM
#79CELL CULTURE PLATFORM FOR SINGLE CELL SORTING AND ENHANCED REPROGRAMMING OF IPSCS
#80CD19 specific chimeric antigen receptor and uses thereof
#81CD19 specific chimeric antigen receptor and uses thereof
#82METHOD FOR THE PRODUCTION OF CELLULAR PARTICULATE WITH ANTITUMOR ACTIVITY
#83Methods for reducing elevated glucose levels
#84CRISPR/Cas screening platform to identify genetic modifiers of tau seeding or aggregation
#85Restimulation of cryopreserved tumor infiltrating lymphocytes
#86Genetically modified stem cells
#87Methods for engineering allogeneic and immunosuppressive resistant T cell for immunotherapy
#88Methods for reprogramming cells and uses thereof
#89Reprogramming somatic cells into pluripotent cells using a vector encoding Oct4 and Sox2
#90T-cells expressing anti-LIV1 chimeric antigen receptor
#91Avian induced pluripotent stem cells and their use
#92TISSUE ORGANOIDS
#93GENOME EDITED CANCER CELL VACCINES
#94IMMUNOMODULATING CELL CIRCUITS
#95NEO-ANTIGEN SPECIFIC T CELLS
#96Method for Treating Cancer
#97Engineered artificial antigen presenting cells for tumor infiltrating lymphocyte expansion
#98NATURAL KILLER T (NKT) CELLS COMPRISING ENGINEERED T CELL RECEPTORS
#99Artificial antigen-presenting cell prepared from HLA-null cell line by using multiplex CRISPR-CAS9 system and use thereof
#100WNT PATHWAY STIMULATION IN REPROGRAMMING SOMATIC CELLS WITH NUCLEAR REPROGRAMMING FACTORS
#101Use of pre T alpha or functional variant thereof for expanding TCR alpha deficient T cells
#102Use of pre T alpha or functional variant thereof for expanding TCR alpha deficient T cells
#103Three-dimensional tissue
#104CD40L EXPRESSING MAMMALIAN CELLS AND THEIR USE
#105Cell Differentiation Marker and its Uses
#106Methods for reprogramming cells and uses thereof
#107Compositions and methods for increasing mesenchymal stromal cell migration to tumors
#108Methods and compositions for producing fatty alcohols
#109METHODS FOR ENGINEERING ALLOGENEIC AND IMMUNOSUPPRESSIVE RESISTANT T CELL FOR IMMUNOTHERAPY
#110Neural cell populations from primate pluripotent stem cells
#111CAR-EXPRESSING NK-92 CELLS AS CELL THERAPEUTIC AGENTS
#112Androgenetic haploid embryonic stem cell (AG-HAESC), and preparation method and use thereof
#113POLYCLONAL GAMMA DELTA T CELLS FOR IMMUNOTHERAPY
#114Engineered artificial antigen presenting cells for tumor infiltrating lymphocyte expansion
#115Chimeric Receptors with 4-1BB Stimulatory Signaling Domain
#116METHOD FOR TREATING CANCER
#117Methods of producing modified natural killer cells and methods of use
#118Methods for expanding immune cells
#119GAMMA DELTA T CELLS AS A TARGET FOR TREATMENT OF SOLID TUMORS
#120Methods for engineering allogeneic and immunosuppressive resistant T cell immunotherapy
#121Universal killer T-cell
#122Cell culture platform for single cell sorting and enhanced reprogramming of iPSCs
#123Enhanced affinity T cell receptors and methods for making the same
#124Use of pre T alpha or functional variant thereof for expanding TCR alpha deficient T cells
#125Method for the generation of genetically modified cells
#126METHOD
#127Artificial antigen presenting cells and uses thereof
#128Means and methods for influencing the stability of antibody producing cells
#129Chimeric Receptors with 4-1BB Stimulatory Signaling Domain
#130Cell Culture Media Composition and Methods of Producing Thereof
#131WNT PATHWAY STIMULATION IN REPROGRAMMING SOMATIC CELLS WITH NUCLEAR REPROGRAMMING FACTORS
#132METHODS OF ISOLATING T CELL RECEPTORS HAVING ANTIGENIC SPECIFICITY FOR A CANCER-SPECIFIC MUTATION
#133Use of PDL1 expressing cells to convert T cells into regulatory T cells
#134CAR-expressing NK-92 cells as cell therapeutic agents
#135Human progenitor T-cells into NK cells
#136Method for preparing and using cell ghost with active factors as synergist of lymphocyte in vitro culture
#137Methods for reprogramming cells and uses thereof
#138T cell expansion
#139Population of isolated chicken cells reprogrammed from somatic cells
#140Polyclonal gamma delta T cells for immunotherapy
#141CD19 specific chimeric antigen receptor and uses thereof
#142Methods for engineering highly active T cell for immunotherapy
#143Methods for engineering allogeneic and highly active t cell for immunotherapy
#144Methods and compositions for producing fatty alcohols
#145Wnt pathway stimulation in reprogramming somatic cells with nuclear reprogramming factors
#146Means and methods for influencing the stability of antibody producing cells
#147CELL CULTURE MEDIA COMPOSITION AND METHODS OF PRODUCING THEREOF
#148Chimeric receptors with 4-1BB stimulatory signaling domain
#149Diffusible factors and cancer cells
#150Use of preTalpha or functional variant thereof for expanding TCRalpha deficient T cells
#151Enhanced affinity T cell receptors and methods for making the same
#152Imaging-aided gene therapy using mesenchymal stem cells as target-delivery vehicle
#153Methods of generating neural stem cells
#154Use of PDL1 expressing cells to convert T cells into regulatory T cells
#155Chimeric receptors with 4-1BB stimulatory signaling domain
#156Chimeric receptors with 4-1BB stimulatory signaling domain
#157Primate pluripotent stem cell expansion without feeder cells and in the presence of FGF and matrigel or Engelbreth-Holm-Swarm tumor cell preparation
#158Producing human CD34+CD7+CD5+CD1a− progenitor T cells and method of treatment
#159Cell culture platform for single cell sorting and enhanced reprogramming of iPSCs
#160Artificial antigen presenting cells and uses thereof
#161Activation and expansion of T-cells using an engineered multivalent signaling platform as a research tool
#162Multi-chain chimeric antigen receptor and uses thereof
#163Compositions for the in vitro derivation and culture of embryonic stem (ES) cell lines with germline transmission capability and for the culture of adult stem cells
#164Somatic cell reprogramming
#165Methods for engineering allogeneic and immunosuppressive resistant T cell for immunotherapy
#166Enriched population of human pluripotent cells with Oct-4 and Sox2 integrated into their genome
#167Methods and compositions for producing fatty alcohols
#168USE OF AUTOLOGOUS EFFECTOR CELLS AND ANTIBODIES FOR TREATMENT OF MULTIPLE MYELOMA
#169USE OF AUTOLOGOUS EFFECTOR CELLS FOR TREATMENT OF MULTIPLE MYELOMA
#170Methods for generating T lymphocytes from hematopoietic stem cells
#171Neural cell populations from primate pluripotent stem cells
#172COMPOSITIONS AND METHODS FOR RE-PROGRAMMING CELLS WITHOUT GENETIC MODIFICATION FOR TREATMENT OF NEUROLOGICAL DISORDERS
#173Methods for reprogramming cells and uses thereof
#174Chimeric receptors with 4-1BB stimulatory signaling domain
#175Methods of generating neural stem cells
#176Engineered Xenogeneic Cells for Repair of Biological Tissue
#177FUNCTIONALIZED ORGANOTYPIC SYSTEMS
#178Exogenous Pax6 nucleic acid expression in primate neural stem cells maintains proliferation without differentiation
#179FEEDER CELLS FOR TARGET CELL INDUCTION
#180Screening methods for human embryonic stem cells
#181Identification of antigenic peptides from multiple myeloma cells
#182Identification of antigenic peptides from multiple myeloma cells
#183Identification of antigenic peptides from multiple myeloma cells
#184EXPANSION OF NK CELLS AND THERAPEUTIC USES THEREOF
#185Method of treatment using organotypically cultured skin tissue comprising NIKS cells that express exogenous HIF-1α
#186CD34+CD7+CD5+CD1a-human progenitor T-cells produced in vitro and methods of using
#187Use of HSA-producing cells
#188Artificial antigen presenting cells and uses therefor
#189REPROGRAMMING CELLS TOWARD A PLURIPOTENT STATE
#190SYSTEM AND METHOD FOR PRODUCING T CELLS
#191METHOD FOR OBTAINING TREG-CELLS
#192Identification of antigenic peptides from multiple myeloma cells
#193Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
#194Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
#195EX-VIVO PRIMING FOR GENERATING CYTOTOXIC T LYMPHOCYTES SPECIFIC FOR NON-TUMOR ANTIGENS TO TREAT AUTOIMMUNE AND ALLERGIC DISEASE
#196Method of treatment using organotypically cultured skin tissue comprising niks cells that express exogenous HIF-1a
#197CARDIAC MYOCYTE MORPHOGENIC COMPOSITIONS AND METHODS OF USE THEREFOR
#198Notch induced natural killer cell generation and therapeutic uses
#199Production of primate neural stem cells through expression of pax6
#200Composition comprising recombinant nucleic acid encoding Sox2, Oct-4, Nanog and Lin28
#201Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
#202IgE antigenic peptides
#203IN VITRO DIFFERENTIATION/INDUCTION OF LYMPHOCYTE FROM STEM CELL HAVING GENOTYPE PROVIDED AFTER GENE RECONSTITUTION
#204Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
#205Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
#206MIXED-CELL GENE THERAPY
#207Culture System for Rapid Expansion of Human Embryonic Stem Cells
#208WNT pathway stimulation in reprogramming somatic cells with nuclear reprogramming factors
#209Activation and expansion of T-cells using an engineered multivalent signaling platform as a research tool
#210Methods of identifying small molecules for renewals, survival and migration of cardiac progenitors
#211Micro-carrier culture system for rapid expansion of human embryonic stem cells
#212Means and methods for influencing the stability of antibody producing cells
#213Methods and compositions for producing fatty alcohols
#214Cell therapy method for the treatment of tumors
#215Use of TGF beta superfamily antagonists and neurotrophins to make neurons from embryonic stem cells
#216Neural cell populations from primate pluripotent stem cells
#217Culture System and Method for Propagation of Human Blastocyst-Derived Stem Cells
#218In vitro production of a cell population using feeder cells
#219Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
#220METHOD OF MAINTENANCE AND EXPANSION OF HEMATOPOIETIC STEM CELLS
#221Keratinocytes expressing exogenous angiogenic growth factors
#222Inducing Premature Senescence to Stabilize Stem Cell Feeder Layer Cells
#223Compositions for the in vitro derivation and culture of embryonic stem (ES) cell lines with germline transmission capability and for the culture of adult stem cells
#224METHODS FOR PROMOTING DOPAMINERGIC NEURONAL DEVELOPMENT BY USING NG4A-SUBFAMILY AND WNT-LIGANDS
#225Obtention of food- or auto-antigen specific TR1 cells from a leukocyte or PBMC population
#226Expansion of NK cells and therapeutic uses thereof
#227Cell therapy method for the treatment of tumors
#228Human embryonic stem cells genetically modified to contain a nucleic acid and cultured with fibroblast growth factor
#229Methods and products for embryonic stem cell culture
#230Reprogramming somatic cells using retroviral vectors comprising Oct-4 and Sox2 genes
#231METHOD FOR OBTAINING ANTIGEN-SPECIFIC TR1 REGULATORY LYMPHOCYTES
#232Cells and methods utilizing same for modifying the electrophysiological function of excitable tissues
#233Methods of identifying small molecules for renewal, survival and migration of cardiac progenitors
#234MIXED-CELL GENE THERAPY
#235Culture system for rapid expansion of human embryonic stem cells
#236PLURIPOTENTIAL EMBRYONIC STEM CELLS AND METHODS OF MAKING SAME
#237Method for growing stem cells on genetically modified supporter cells
#238Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
#239Development of natural killer cells and functional natural killer cell lines
#240Use of islet 1 as a marker for isolating or generating stem cells
#241Methods for promoting dopaminergic neuronal development by using ng4a-subfamily and wnt-ligands
#242Bioartificial device for propagation of tissue, preparation and uses thereof
#243Mixed-cell gene therapy
#244Modified cell line and method for expansion of NK cell
#245WNT4 in supporting lymphopoiesis
#246Artificial antigen presenting cells and uses therefor
#247Method and composition for skin grafts
#248In vitro induction of antigen-specific T-cells using dendritic cell-tumor cell or dendritic cell-viral cell derived immunogens
#249Human embryonic stem cells having genetic modifications
#250Use of TGF beta superfamily antagonists to make dopaminergic neurons from embryonic stem cells
#251System for expanding and differentiating human embryonic stem cells
#252Using fibroblast growth factor to establish a line of embryonic stem cells
#253Antigen presenting system and methods for activation of T-cells
#254Use of cyclic AMP and ascorbic acid to produce dopaminergic neurons from embryonic stem cells
#255Genetic screen for bioactive peptides
#256Compositions for the in vitro derivation and culture of embryonic stem (es) cell lines with germline transmission capability and for the culture of adult stem cells
#257Method for inducing cytotoxic T lymphocyte
#258Dopaminergic neurons and proliferation-competent precursor cells for treating Parkinson's disease
#259Medium for growing human embryonic stem cells
#260Organotypically cultured skin tissue comprising NIKS cells that express exogenous HIF-1a
#261Antigen presenting cells, method for their preparation and their use for cancer vaccines
#262Enhancement of angiogenesis to grafts using cells engineered to produce growth factors